CDMO

R&D

Completing a successful tech transfer

Tech transfers can be difficult and every one is unique, but the right tips can help. Lannett CDMO's Grant Brock and Frantz Maignan weigh in.

News

Lonza adds biologics capacity with $1.2bn Roche deal

Roche is set to raise $1.2 billion from the sale of a US biologics manufacturing facility to Swiss contract development and manufacturing organisation (CDMO) Lonza, part o

News

US bill paints some Chinese biotechs as security threats

Legislation tabled in the US is seeking to block Chinese life sciences companies from claiming federal funding and contracts on the grounds they are a national security co

R&D

From pandemic spotlight to global progress: Navigating techn...

In an increasingly interconnected world, the transfer of technology between different stakeholders and across borders is becoming an integral process in many industries, including pharma

News

Change at the top at Recipharm as strategy shifts

Swedish contract development and manufacturing organisation (CDMO) Recipharm has appointed former Nestlé Health Sciences’ chief executive Greg Behar as its new CEO, replac

R&D

The pharma trends leading to higher demand for CDMOs

Recent discoveries and advances in pharma for lower demand illnesses/indications have resulted in an increase in the number of smaller start-up organisations.

Completing a successful tech transfer

Lonza adds biologics capacity with $1.2bn Roche deal

US bill paints some Chinese biotechs as security threats

From pandemic spotlight to global progress: Navigating techn...

Change at the top at Recipharm as strategy shifts

The pharma trends leading to higher demand for CDMOs

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

CDMO

Editor's Picks